Literature DB >> 8741612

Establishment and characterization of a new canine B-cell leukemia cell line.

M Nakaichi1, Y Taura, M Kanki, K Mamba, Y Momoi, H Tsujimoto, S Nakama.   

Abstract

A new cell line derived from a spontaneous canine leukemia was established and designated GL-1. The cells have been cultured in a floating fashion and passaged for over two years. They were round with rich cytoplasm containing many rough endoplasmic reticula and mitochondria. Peroxidase staining was negative. The nuclei of many cells were round, but segmented nuclei were seen frequently. The doubling time of the cells was 27.3 hr and they had 78 chromosomes. Surface marker analysis using monoclonal antibodies (MABs) and flowcytometry revealed that GL-1 possessed CD45 and surface IgG. However, the cells did not react with MABs detecting T-cell markers. These results indicate that GL-1 has a lymphocytic lineage and is derived from a B-cell leukemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741612     DOI: 10.1292/jvms.58.469

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  26 in total

1.  Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells.

Authors:  Satoshi Kambayashi; Kouji Minami; Yuka Ogawa; Takehiro Hamaji; Chung Chew Hwang; Masaya Igase; Hiroko Hiraoka; Takako Shimokawa Miyama; Shunsuke Noguchi; Kenji Baba; Takuya Mizuno; Masaru Okuda
Journal:  Can J Vet Res       Date:  2015-07       Impact factor: 1.310

Review 2.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

Review 3.  Beyond tradition and convention: benefits of non-traditional model organisms in cancer research.

Authors:  Rebecca M Harman; Sanjna P Das; Arianna P Bartlett; Gat Rauner; Leanne R Donahue; Gerlinde R Van de Walle
Journal:  Cancer Metastasis Rev       Date:  2020-10-28       Impact factor: 9.264

4.  3D-culture models as drug-testing platforms in canine lymphoma and their cross talk with lymph node-derived stromal cells.

Authors:  Ju Hyun An; Woo Jin Song; Qiang Li; Dong Ha Bhang; Hwa Young Youn
Journal:  J Vet Sci       Date:  2021-03-05       Impact factor: 1.672

5.  NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent manner.

Authors:  Alexandra Hebar; Barbara C Rütgen; Edgar Selzer
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

6.  FLT3 mutations in canine acute lymphocytic leukemia.

Authors:  Steven E Suter; George W Small; Eric L Seiser; Rachael Thomas; Matthew Breen; Kristy L Richards
Journal:  BMC Cancer       Date:  2011-01-27       Impact factor: 4.430

7.  Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma.

Authors:  Satoshi Kambayashi; Masaya Igase; Kosuke Kobayashi; Ayana Kimura; Takako Shimokawa Miyama; Kenji Baba; Shunsuke Noguchi; Takuya Mizuno; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2015-06-06       Impact factor: 1.267

Review 8.  Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.

Authors:  Maurice Zandvliet; Erik Teske
Journal:  Vet Sci       Date:  2015-08-12

9.  Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.

Authors:  James W Wells; Christopher H Evans; Milcah C Scott; Barbara C Rütgen; Timothy D O'Brien; Jaime F Modiano; Goran Cvetkovic; Slobodan Tepic
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  The regulation of the expression of ABCG2 gene through mitogen-activated protein kinase pathways in canine lymphoid tumor cell lines.

Authors:  Hirotaka Tomiyasu; Yuko Goto-Koshino; Yasuhito Fujino; Koichi Ohno; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2013-10-25       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.